CN106215079A - A kind of Chinese medicine composition treating hyperosteogeny - Google Patents
A kind of Chinese medicine composition treating hyperosteogeny Download PDFInfo
- Publication number
- CN106215079A CN106215079A CN201610562294.6A CN201610562294A CN106215079A CN 106215079 A CN106215079 A CN 106215079A CN 201610562294 A CN201610562294 A CN 201610562294A CN 106215079 A CN106215079 A CN 106215079A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- ramulus
- chinese medicine
- marsili
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- ONBFMOPYFIVJNC-KYJUHHDHSA-N CCN(C)C(Oc1cc(C(N[C@@H](Cc2ccccc2)[C@H](CNCc2ccccc2)O)=O)cc(CNCC#C)c1)=O Chemical compound CCN(C)C(Oc1cc(C(N[C@@H](Cc2ccccc2)[C@H](CNCc2ccccc2)O)=O)cc(CNCC#C)c1)=O ONBFMOPYFIVJNC-KYJUHHDHSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of Chinese medicine composition treating hyperosteogeny, it comprises the material of following weight portion: external preparation: red 20 parts of old monarch, cartilage Ramulus et Folium Mussaendae Pubescentis 25 parts, Radix seu Caulis Kadsurae Heteroclitae 15 parts, Olibanum 10 parts, blood phoenix grass 15 parts, Myrrha 10 parts, viscous fragrant skin 10 parts, Herba Lycopodii 15 parts, Firmiana platanifolia (Linn. f.) Marsili 10 parts, Ramulus et folium taxi cuspidatae 20 parts, pale reddish brown Firmiana platanifolia (Linn. f.) Marsili 10 parts and Radix Arnebiae (Radix Lithospermi) 10 parts;Oral preparations: Caulis seu Radix Schisandrae Henryi 25 parts, Radix Angelicae Sinensis 25 parts, Lignum Sappan 10 parts, Ramulus Uncariae Cum Uncis 10 parts, Radix Salviae Miltiorrhizae 10 parts, Rhizoma Paridis 10 parts, Radix Dipsaci 10 parts, red 10 parts of old monarch, Rhizoma Corydalis 10 parts, 10 parts of Semen Persicae, Ramulus et Folium Mussaendae Pubescentis 10 parts, 6 parts of Radix Glycyrrhizae and Radix Achyranthis Bidentatae 10 parts.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of Chinese medicine composition treating hyperosteogeny.
Background technology
Hyperosteogeny is also known as Hypertrophic osteoarthritis, and including constitutional and Secondary cases, the most idiopathic Basic disease cause is,
The most aging and degeneration after people's body maturation, the performance in terms of osteoarthrosis;Secondary cases refers to because of certain known reason, such as
Wound, operation or other obvious factors and the cartilage destruction that causes, or articulation structure changes.Due to articular surface friction or pressure not
The factors such as balance, cause the degeneration of articular surface.
Summary of the invention
It is an object of the invention to provide a kind of Chinese medicine composition treating hyperosteogeny.
In order to realize the purpose of the present invention, the present invention provides a kind of Chinese medicine composition treating hyperosteogeny, under it comprises
The material of row weight portion:
External preparation: red 20 parts of old monarch, cartilage Ramulus et Folium Mussaendae Pubescentis 25 parts, Radix seu Caulis Kadsurae Heteroclitae 15 parts, Olibanum 10 parts, blood phoenix grass 15 parts, do not have
Medicine 10 parts, viscous fragrant skin 10 parts, Herba Lycopodii 15 parts, Firmiana platanifolia (Linn. f.) Marsili 10 parts, Ramulus et folium taxi cuspidatae 20 parts, pale reddish brown Firmiana platanifolia (Linn. f.) Marsili 10 parts and Radix Arnebiae (Radix Lithospermi) 10 parts;
Oral preparations: Caulis seu Radix Schisandrae Henryi 25 parts, Radix Angelicae Sinensis 25 parts, Lignum Sappan 10 parts, Ramulus Uncariae Cum Uncis 10 parts, Radix Salviae Miltiorrhizae 10 parts, Rhizoma Paridis 10 parts, Radix Dipsaci 10
Part, red 10 parts of old monarch, Rhizoma Corydalis 10 parts, 10 parts of Semen Persicae, Ramulus et Folium Mussaendae Pubescentis 10 parts, 6 parts of Radix Glycyrrhizae and Radix Achyranthis Bidentatae 10 parts.
Preferably, the Chinese medicine composition for the treatment of hyperosteogeny of the present invention comprises the material of following weight portion: 0.2 part
The material with following structural:
The present invention also provide for the material with following structural preparation treatment hyperosteogeny medicine in purposes:
Medicine of the present invention has liver-kidney tonifying, promoting blood circulation and stopping pain, effect of the solid bone of strong muscle, can effectively treat hyperosteogeny.
Detailed description of the invention
The present invention is further illustrated below by embodiment.It should be understood that embodiments of the invention are for illustrating
The present invention rather than limitation of the present invention.The simple modifications that the present invention is carried out by the essence according to the present invention broadly falls into the present invention
Claimed scope.Unless otherwise stated, the percent in the present invention is percetage by weight.
Embodiment 1
External preparation: red 20 grams of old monarch, cartilage Ramulus et Folium Mussaendae Pubescentis 25 grams, Radix seu Caulis Kadsurae Heteroclitae 15 grams, Olibanum 10 grams, blood phoenix grass 15 grams, do not have
Medicine 10 grams, viscous fragrant skin 10 grams, Herba Lycopodii 15 grams, Firmiana platanifolia (Linn. f.) Marsili 10 grams, Ramulus et folium taxi cuspidatae 20 grams, pale reddish brown Firmiana platanifolia (Linn. f.) Marsili 10 grams and Radix Arnebiae (Radix Lithospermi) 10 grams, pulverize,
Crossing 100 mesh sieves, mix homogeneously obtains powder.
Oral preparations: Caulis seu Radix Schisandrae Henryi 25 grams, Radix Angelicae Sinensis 25 grams, Lignum Sappan 10 grams, Ramulus Uncariae Cum Uncis 10 grams, Radix Salviae Miltiorrhizae 10 grams, Rhizoma Paridis 10 grams, Radix Dipsaci 10
Gram, red 10 grams of old monarch, Rhizoma Corydalis 10 grams, 10 grams of Semen Persicae, Ramulus et Folium Mussaendae Pubescentis 10 grams, 6 grams of Radix Glycyrrhizae and Radix Achyranthis Bidentatae 10 grams, pulverize, cross 100 mesh sieves,
Mix homogeneously obtains powder.
Embodiment 2
Compound has a following structural:
Experimental example
Age in August SPF level Healthy female SD rat 40, body weight (350 ± 10) g.II Collagen Type VI, complete Freund's adjuvant are (beautiful
Sigma company of state produces);Rat IL-1 β enzyme-linked immunologic detecting kit (production of R&D company of the U.S.).
It is divided into blank group 10, model group 10, embodiment 2 compound group 10 and methotrexate group 10.Take II type
Collagen protein is dissolved in 0.1mol/L acetic acid, is made into the solution that concentration is 2mg/mL, and 4 DEG C overnight.Next day helps with complete Freund
Agent makes emulsion with 1: 1 volume mixture.Repeatedly aspirate with syringe, until mixture is complete, fully emulsified, drip with emulsion
Entering in water the loosest, one-tenth drop-wise floats on water and is that emulsifying is complete.Take the collagen-induced property rheumatoid arthritis model after emulsifying
(CIA) modeling agent, in addition to blank group, after carrying out disinfection rat root of the tail portion, back, right metapedes toes portion with 75% ethanol, presses
0.4mL/, only in upper 3 intradermal injections, sees circular skin mound and is swollen with, for injecting successfully.After modeling the 7th day with same method 3 point
Booster injection 1 time.After booster injection, rat foot claw serious swelling, articulatio talocruralis diameter increasing degree >=12mm, rear solid end volume increase
Amplitude >=0.80mL is modeling success.
Within after modeling the 14th day, rise and start to be administered.Model group: give normal saline gavage 1mL/1000g body weight;Embodiment 2 is changed
The compound of compound group: 0.05g adds 1000mL normal saline and becomes suspension, gives gavage 1mL/1000g body weight;Positive drug
The methotrexate of methotrexate group: 0.05g adds 1000mL normal saline and becomes suspension, gives gavage 1mL/1000g body weight.
Equal every day 1 time, successive administration 21d above.
By rat after intraperitoneal anesthesia, femoral artery takes blood about 4mL, is centrifuged 20min with 3000r/min, draws serum standby
With, by rat blood serum IL-1 β.It is measured according to the method for the requirement of detection kit.
Using SPSS15.0 statistical package that every detection data carry out variance analysis, all analytical data results are all adopted
By mean ± standard deviationRepresenting, P < 0.05, for there are differences, has statistical significance.
Each group of rat blood serum IL-1 β is affected change compare (ng/L,) see table
Compare with blank group, * P < 0.05;Compare with model group, #P < 0.05;Compare with positive drug group, Δ P < 0.05.
Originally test result indicate that, medicine of the present invention can effectively alleviate the swelling degree in RA joint, hence it is evident that reduces IL-1 β's
Content, thus block inflammatory reaction, improve function of joint, delay the process of RA, alleviate the destruction of RA.Medicine of the present invention is described
Thing has obvious therapeutic action to RA.
Claims (3)
1. the Chinese medicine composition treating hyperosteogeny, it is characterised in that it comprises the material of following weight portion:
External preparation: red 20 parts of old monarch, cartilage Ramulus et Folium Mussaendae Pubescentis 25 parts, Radix seu Caulis Kadsurae Heteroclitae 15 parts, Olibanum 10 parts, blood phoenix grass 15 parts, Myrrha 10
Part, viscous fragrant skin 10 parts, Herba Lycopodii 15 parts, Firmiana platanifolia (Linn. f.) Marsili 10 parts, Ramulus et folium taxi cuspidatae 20 parts, pale reddish brown Firmiana platanifolia (Linn. f.) Marsili 10 parts and Radix Arnebiae (Radix Lithospermi) 10 parts;
Oral preparations: Caulis seu Radix Schisandrae Henryi 25 parts, Radix Angelicae Sinensis 25 parts, Lignum Sappan 10 parts, Ramulus Uncariae Cum Uncis 10 parts, Radix Salviae Miltiorrhizae 10 parts, Rhizoma Paridis 10 parts, Radix Dipsaci 10 parts,
Red 10 parts of old monarch, Rhizoma Corydalis 10 parts, 10 parts of Semen Persicae, Ramulus et Folium Mussaendae Pubescentis 10 parts, 6 parts of Radix Glycyrrhizae and Radix Achyranthis Bidentatae 10 parts.
The Chinese medicine composition for the treatment of hyperosteogeny the most according to claim 1, it is characterised in that it comprises following weight portion
Material: the material with following structural of 0.2 part:
3. there is the material of the following structural purposes in the medicine of preparation treatment hyperosteogeny:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610562294.6A CN106215079A (en) | 2016-07-18 | 2016-07-18 | A kind of Chinese medicine composition treating hyperosteogeny |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610562294.6A CN106215079A (en) | 2016-07-18 | 2016-07-18 | A kind of Chinese medicine composition treating hyperosteogeny |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106215079A true CN106215079A (en) | 2016-12-14 |
Family
ID=57519107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610562294.6A Pending CN106215079A (en) | 2016-07-18 | 2016-07-18 | A kind of Chinese medicine composition treating hyperosteogeny |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106215079A (en) |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1091649A (en) * | 1993-08-04 | 1994-09-07 | 付云辉 | Stasis reducing liquor |
CN1275402A (en) * | 1999-11-30 | 2000-12-06 | 王福伟 | Powder medicine for treating hyperosteogeny |
CN1331983A (en) * | 2001-03-13 | 2002-01-23 | 曲丽萍 | Hyperosteogeny treating medicine |
CN1459293A (en) * | 2002-05-20 | 2003-12-03 | 焦青山 | Traditional Chinese medicine for treating prolapse of lumbar intervertebral disc and osteoproliferation |
CN101185672A (en) * | 2007-12-19 | 2008-05-28 | 崔月清 | Orally-administered traditional Chinese medicine decoction for treating lumbar hyperosteogeny |
CN104547034A (en) * | 2014-12-30 | 2015-04-29 | 曲成明 | Traditional Chinese medicinal preparation for treating hyperosteogeny and method for preparing preparation |
CN106038562A (en) * | 2016-07-18 | 2016-10-26 | 郝红娟 | Medicine for treating rheumatoid arthritis |
CN106038557A (en) * | 2016-07-18 | 2016-10-26 | 李振芳 | Medicine for treating rheumatoid arthritis |
CN106075347A (en) * | 2016-07-18 | 2016-11-09 | 王明亮 | One treats cervical and lumbar diseases and arthritic external application Chinese medicine unguentum |
CN107158093A (en) * | 2017-07-20 | 2017-09-15 | 东阳市人民医院 | A kind of external application hot compress preparation for treating lumbar vertebrae hyperosteogeny |
-
2016
- 2016-07-18 CN CN201610562294.6A patent/CN106215079A/en active Pending
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1091649A (en) * | 1993-08-04 | 1994-09-07 | 付云辉 | Stasis reducing liquor |
CN1275402A (en) * | 1999-11-30 | 2000-12-06 | 王福伟 | Powder medicine for treating hyperosteogeny |
CN1331983A (en) * | 2001-03-13 | 2002-01-23 | 曲丽萍 | Hyperosteogeny treating medicine |
CN1459293A (en) * | 2002-05-20 | 2003-12-03 | 焦青山 | Traditional Chinese medicine for treating prolapse of lumbar intervertebral disc and osteoproliferation |
CN101185672A (en) * | 2007-12-19 | 2008-05-28 | 崔月清 | Orally-administered traditional Chinese medicine decoction for treating lumbar hyperosteogeny |
CN104547034A (en) * | 2014-12-30 | 2015-04-29 | 曲成明 | Traditional Chinese medicinal preparation for treating hyperosteogeny and method for preparing preparation |
CN106038562A (en) * | 2016-07-18 | 2016-10-26 | 郝红娟 | Medicine for treating rheumatoid arthritis |
CN106038557A (en) * | 2016-07-18 | 2016-10-26 | 李振芳 | Medicine for treating rheumatoid arthritis |
CN106075347A (en) * | 2016-07-18 | 2016-11-09 | 王明亮 | One treats cervical and lumbar diseases and arthritic external application Chinese medicine unguentum |
CN107158093A (en) * | 2017-07-20 | 2017-09-15 | 东阳市人民医院 | A kind of external application hot compress preparation for treating lumbar vertebrae hyperosteogeny |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105663607B (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
CN102058673B (en) | Chinese medicine composition for expelling wind and removing dampness and preparation method thereof | |
CN103372073A (en) | Red rice and hawthorn medicinal composition for regulating blood fat and preparation method of composition | |
CN106215079A (en) | A kind of Chinese medicine composition treating hyperosteogeny | |
CN103211957A (en) | Alcohol relieving and liver protecting composition and application thereof | |
CN101214289A (en) | Chinese medicinal composition for treating thrombocytopenic purpura and preparation thereof | |
CN114903961A (en) | Composition for treating osteoarthropathy and application thereof | |
CN112843140B (en) | Medicine for treating thirst and conjunctival congestion caused by diabetes, preparation method and application | |
CN109876127B (en) | Blood-nourishing angelica sinensis capsule and preparation method thereof | |
CN106038562A (en) | Medicine for treating rheumatoid arthritis | |
CN103372040B (en) | Monas cuspurpureus Went Rhizoma Chuanxiong drug regimen of a kind of adjusting blood lipid and preparation method thereof | |
CN102357232B (en) | Traditional Chinese medicine for treating breast disease and preparation method thereof | |
CN1292275A (en) | Chinese medicine preparation for curing postpartum disease of woman | |
CN102205104B (en) | Compound oral solution for treating infantile cough and preparation method thereof | |
CN101028319B (en) | Chinese-medicine compound preparation against coronary heart disease and its production | |
CN109999124A (en) | A kind of Black people join deer whip slice prescription and preparation method thereof | |
CN107469014A (en) | A kind of pharmaceutical composition for treating female mammary gland proliferation disease and preparation method thereof | |
CN115105547B (en) | Composition with antithrombotic effect and application thereof | |
CN1140282C (en) | External use medicine for curing sexual disorder for male | |
CN101167796B (en) | Monascus and red sage root composition for preventing and treating cardiovascular and cerebrovascular diseases | |
CN105395650A (en) | Applications of Shu Gan Ning preparation in preparation of medicines treating osteoporosis and complications of the osteoporosis | |
CN100502912C (en) | Medicine for treating deficiency syndrome, its preparing process and usage | |
CN100339133C (en) | Composition of nanometer SOD and astragalus root or its extract and its preparation method | |
CN106361829A (en) | Traditional Chinese medicine composition for treating ischemic stroke, preparation and preparation method thereof | |
CN100364560C (en) | Chinese medicine preparation for preventing and treating chronic liver fibrosis and cirrhosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161214 |
|
WD01 | Invention patent application deemed withdrawn after publication |